Vicore Pharma (Sweden) Market Value
| VICO Stock | SEK 7.76 0.06 0.78% |
| Symbol | Vicore |
Vicore Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vicore Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vicore Pharma.
| 09/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Vicore Pharma on September 28, 2024 and sell it all today you would earn a total of 0.00 from holding Vicore Pharma Holding or generate 0.0% return on investment in Vicore Pharma over 60 days. Vicore Pharma is related to or competes with Hansa Biopharma, Xbrane Biopharma, and BioArctic. Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company More
Vicore Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vicore Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vicore Pharma Holding upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 52.59 | |||
| Value At Risk | (4.36) | |||
| Potential Upside | 3.39 |
Vicore Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vicore Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vicore Pharma's standard deviation. In reality, there are many statistical measures that can use Vicore Pharma historical prices to predict the future Vicore Pharma's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.94) | |||
| Total Risk Alpha | (1.87) | |||
| Treynor Ratio | (0.72) |
Vicore Pharma Holding Backtested Returns
Vicore Pharma Holding owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Vicore Pharma Holding exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vicore Pharma's Risk Adjusted Performance of (0.08), coefficient of variation of (840.51), and Variance of 45.13 to confirm the risk estimate we provide. The entity has a beta of 1.12, which indicates a somewhat significant risk relative to the market. Vicore Pharma returns are very sensitive to returns on the market. As the market goes up or down, Vicore Pharma is expected to follow. At this point, Vicore Pharma Holding has a negative expected return of -0.78%. Please make sure to validate Vicore Pharma's total risk alpha, maximum drawdown, and the relationship between the jensen alpha and treynor ratio , to decide if Vicore Pharma Holding performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.46 |
Modest reverse predictability
Vicore Pharma Holding has modest reverse predictability. Overlapping area represents the amount of predictability between Vicore Pharma time series from 28th of September 2024 to 28th of October 2024 and 28th of October 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vicore Pharma Holding price movement. The serial correlation of -0.46 indicates that about 46.0% of current Vicore Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Vicore Pharma Holding lagged returns against current returns
Autocorrelation, which is Vicore Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vicore Pharma's stock expected returns. We can calculate the autocorrelation of Vicore Pharma returns to help us make a trade decision. For example, suppose you find that Vicore Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vicore Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vicore Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vicore Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vicore Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Vicore Pharma Lagged Returns
When evaluating Vicore Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vicore Pharma stock have on its future price. Vicore Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vicore Pharma autocorrelation shows the relationship between Vicore Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Vicore Pharma Holding.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.